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Abstract
Introduction: Prediction	of	Alzheimer’s	 disease	 (AD)	progression	based	on	baseline	
measures allows us to understand disease progression and has implications in deci-
sions	concerning	treatment	strategy.	To	this	end,	we	combine	a	predictive	multi-	task	
machine	learning	method	(cFSGL)	with	a	novel	MR-	based	multivariate	morphometric	
surface	 map	 of	 the	 hippocampus	 (mTBM)	 to	 predict	 future	 cognitive	 scores	 of	
patients.
Methods: Previous	work	has	 shown	 that	a	multi-	task	 learning	 framework	 that	per-
forms	prediction	of	all	future	time	points	simultaneously	(cFSGL)	can	be	used	to	en-
code both sparsity as well as temporal smoothness. The authors showed that this 
method	is	able	to	predict	cognitive	outcomes	of	ADNI	subjects	using	FreeSurfer-	based	
baseline	MRI	features,	MMSE	score	demographic	information	and	ApoE	status.	Whilst	
volumetric	information	may	hold	generalized	information	on	brain	status,	we	hypoth-
esized	that	hippocampus	specific	information	may	be	more	useful	in	predictive	mod-
eling	of	AD.	To	this	end,	we	applied	a	multivariate	tensor-	based	parametric	surface	
analysis	method	(mTBM)	to	extract	features	from	the	hippocampal	surfaces.
Results: We	combined	mTBM	features	with	traditional	surface	features	such	as	mid-
dle	axis	distance,	the	Jacobian	determinant	as	well	as	2	of	the	Jacobian	principal	eigen-
values	 to	 yield	 7	 normalized	 hippocampal	 surface	 maps	 of	 300	 points	 each.	 By	
combining	these	7	×	300	=	2100	features	together	with	the	previous	~350	features,	
we illustrate how this type of sparsifying method can be applied to an entire surface 
map of the hippocampus that yields a feature space that is 2 orders of magnitude 
larger than what was previously attempted.
Conclusions: By	 combining	 the	 power	 of	 the	 cFSGL	 multi-	task	 machine	 learning	
framework	with	the	addition	of	AD	sensitive	mTBM	feature	maps	of	the	hippocampus	
surface,	we	are	able	to	improve	the	predictive	performance	of	ADAS	cognitive	scores	
6,	12,	24,	36	and	48	months	from	baseline.
K E Y W O R D S
Alzheimer’s	Disease,	dementia,	hippocampus,	machine	learning,	multi-task	learning,	tensor-
based morphometry
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1  | INTRODUCTION
Recent	 work	 in	 psychological	 testing	 (Caselli	 et	al.,	 2013),	 genetic	
studies	 (Elias-	Sonnenschein	 et	al.,	 2013),	 magnetic	 resonance	 (MR)	
imaging	 (Teipel	 et	al.,	 2013),	 positron	 emission	 tomography	 (PET)	
imaging	(Becker	et	al.,	2013),	cerebral	spinal	fluid	(CSF)	measurements	
(Blennow	&	Zetterberg,	 2013),	 cardiovascular	 status	 (Hajjar,	 Brown,	
Mack,	&	Chui,	 2013)	 and	others	 have	yielded	 tremendous	 amounts	
of	 diagnostic	 data	 for	 diagnosing	 and	 staging	 dementias,	 especially	
Alzheimer’s	disease	(AD).	Moreover,	many	of	these	studies	now	also	
include	 longitudinal	 information	 (Caselli	 et	al.,	 2013;	 Mueller	 et	al.,	
2005).	This	 has	 led	 to	 a	 problem	often	 referred	 to	 as	 the	 ‘curse	 of	
dimensionality’,	where	 the	 size	 (number	 of	 dimensions)	 of	 the	 data-
set makes it difficult to perform numerical analyses on the data. This 
in turn makes it increasingly difficult to draw consistent conclusions 
from the dataset. Traditional approaches to dimension reduction elim-
inates variables / dimensions based on clinical assumptions and allows 
us	 to	 test	 specific	hypothesis	 about	 the	disease	model.	However,	 it	
does not lend itself to discovering new correlations or allow for all 
inclusive models that are consistent across all dimensions. These 
problems become even more important when trying to improve pre-
dictions using machine learning techniques. This is mainly because at 
a point the predictive power of the model ceases to increase by just 
adding more information or dimensions. The question is then about 
how	 to	 select	 the	 “correct”	 features	 to	maximize	 predictive	 power.	
Zhou,	Liu,	Narayan,	Ye,	and	Ye	(2013)	outlines	a	method	that	simulta-
neously enforces low dimensionality through sparsity of weights and 
temporal	smoothness	of	the	predicted	behavioral	scores	at	6,	12,	24,	
36	and	48	months.	This	paper	leverages	this	method,	built	specifically	
for	progressive	disease	models,	such	as	AD,	together	with	multivari-
ate	tensor-	based	morphometric	(mTBM)	features	(Wang,	Yuan,	et	al.,	
2010)	of	the	hippocampus	to	predict	AD	progression	up	to	48	months	
from	the	baseline	MRI	measurement.	The	goal	is	to	evaluate	the	pre-
dictive	power	of	mTBM	against	those	of	cortical	thickness	and	other	
FreeSurfer-	based	features,	demographic	information	(sex	and	age)	as	
well	as	genetic	information	(ApoE-	ε4	Copies).
Alzheimer’s	Disease	is	characterized	by	non-	focal	deterioration	of	
brain tissue and many attempts have been made at imaging this phe-
nomenon.	This	includes	the	use	multiple	modalities	including	CT,	PET	
and	MRI.	PET	has	been	a	powerful	technique	for	 imaging	AD,	espe-
cially	with	the	development	of	the	Pittsburgh	Compound	B	(PiB)	tracer	
that	 enhances	 beta-	amyloid	 plaques	 (Klunk	 et	al.,	 2004).	 However,	
MRI	is	more	commonly	used	because	of	the	lack	of	ionizing	radiation	
and	good	white	matter	/	grey	matter	tissue	contrast.	MR	also	allows	
for	multiple	 image	contrasts	to	be	generated	in	a	single	session.	T1-	
weighted high resolution structural images have revealed widespread 
atrophy	of	the	both	white	matter	and	gray	matter	tissues.	In	particular,	
the	deep	gray	matter	structures	–	particularly,	the	hippocampus	-	cor-
relate	strongly	with	AD	progression	(Barber,	Ballard,	McKeith,	Gholkar,	
&	O’	Brien,	2000;	Bozzali,	Franceschi,	Falini,	&	Pontesilli,	2001;	Jack,	
Shiung,	Gunter,	&	O’	Brien,	2004;	Jack	et	al.,	1999;	Killiany,	Hyman,	
Gomez-	Isla,	 &	Moss,	 2002;	 Petersen,	 Jack,	 Xu,	Waring,	 &	O’	 Brien,	
2000;	 deToledo-Morrell	 et	 al.,	 2004;	 Xu,	 Jack,	O’	 Brien,	 Kokmen,	&	
Smith,	2000).	Similarly,	diffusion	weighted	 imaging	has	revealed	dis-
ruption of a number of crucial white matter tracts associated with the 
limbic	system	(Bozzali,	Falini,	&	Franceschi,	2002;	Bozzali	et	al.,	2001;	
Choi,	Lim,	&	Monteiro,	2005;	Chua,	Wen,	&	Slavin,	2008;	Clerx,	Visser,	
Verhey,	 &	Aalten,	 2012;	 Concha,	Gross,	 &	 Beaulieu,	 2005;	Douaud	
et	al.,	 2011;	 Frisoni,	 Fox,	 Jack,	 &	 Scheltens,	 2010;	 Jack,	 Bernstein,	
&	 Fox,	 2008;	 Jahng	 et	al.,	 2011;	 Lo,	 Wang,	 Chou,	 &	Wang,	 2010;	
Nakata	et	al.,	2009;	Rose,	Chen,	Chalk,	&	Zelaya,	2000;	Sexton,	Kalu,	
Filippini,	&	Mackay,	2011;	Takahashi,	Yonezawa,	Takahashi,	&	Kudo,	
2002;	 Yoshiura,	 Mihara,	 Ogomori,	 &	 Tanaka,	 2002;	 Zhang,	 Schuff,	
Ching,	 &	 Tosun,	 2011;	 Zhang,	 Schuff,	 Du,	 Rosen,	 &	 Kramer,	 2009;	
Zhang,	Schuff,	Jahng,	Bayne,	&	Mori,	2007).	Functional	connectivity	
MRI	has	also	shown	decreases	 in	the	default	mode	as	well	as	other	
brain	 networks.	 Clinically,	 the	 current	AD	 diagnosis	 criteria	 include	
the	use	of	(1)	MRI,	(2)	PET	as	well	as	(3)	beta-	amyloid	load	within	the	
cerebral	 spinal	 fluid	 (McKhann,	 Knopman,	 &	 Chertkow,	 2011;	 Ray,	
Britschgi,	Herbert,	&	Takeda-	Uchimura,	2007).	To	measure	severity	of	
dementia,	tests	such	as	MMSE	and	CDR	are	often	used	(Tan:2011vt,	
OBryant:2008bk,	Morris:1997vu).
As	MR	 imaging	 has	 become	more	 ubiquitous	 as	 a	 research	 and	
clinical	 tool,	 there	 has	 been	 an	 effort	 in	 developing	 image-	based	
features	 that	are	 increasingly	sensitive	 to	AD	progression	as	well	as	
the	 conversion	 from	Mildly	Cognitively	 Impaired	 (MCI)	 to	AD.	Early	
attempts	used	volumetric	measurements	of	tissue	types	(WM	or	GM)	
and then the volume of specific structures such as the hippocampus 
(De	 Jong,	Van	 der	 Hiele,	Veer,	 &	 Houwing,	 2008;	 Fox,	Warrington,	
&	Freeborough,	1996;	Frisoni	et	al.,	2010;	Jack	et	al.,	2008;	Laakso,	
Partanen,	 Riekkinen,	 &	 Lehtovirta,	 1996;	 Ridha,	 Barnes,	 Bartlett,	 &	
Godbolt,	 2006;	 Scahill,	 Schott,	 &	 Stevens,	 2002;	 Schuff,	 Woerner,	
Boreta,	Kornfield,	&	Shaw,	2009).	Attempts	were	also	made	at	quan-
tifying the degree of deformation associated with the atrophying 
demented	brain	using	tensor-	based	morphometric	(TBM)	techniques	
(Baron,	Chetelat,	Desgranges,	&	Perchey,	2001;	Grossman,	McMillan,	
Moore,	Ding,	&	Glosser,	2004;	Hirata,	Matsuda,	Nemoto,	Ohnishi,	&	
Hirao,	2005;	Hua,	Leow,	Parikshak,	Lee,	&	Chiang,	2008;	Hua	et	al.,	
2009;	 Hua	 et	 al.,	 2008;	 Karas,	 Burton,	 Rombouts,	 &	Van	 Schijndel,	
2003;	Lerch,	Pruessner,	Zijdenbos,	&	Hampel,	2005;	Oishi	et	al.,	2009;	
Salat,	Buckner,	Snyder,	&	Greve,	2004;	Teipel,	Born,	Ewers,	Bokde,	&	
Reiser,	2007;	Thompson,	Hayashi,	Sowell,	&	Gogtay,	2004).	In	addition	
to	volumetric	deformations,	(Shi,	Thompson,	et	al.	2013)	applied	multi-
variate	TBM	(mTBM)	to	the	hippocampus	surface	and	showed	marked	
improvement	in	sensitivity	of	detecting	AD	progression.
At	 the	 same	 time,	 the	machine	 learning	 community	 recognized	
the utility in predicting disease progression as a means of character-
izing	AD	disease	progression.	 It	allows	for	an	 inclusive	 look	at	how	
the different diagnostic indicators account for observed changes. 
However,	 researchers	were	 faced	with	 finding	selecting	meaningful	
features to be used as well as how to incorporate data with multiple 
time	 points	 (Davatzikos,	 Fan,	Wu,	 Shen,	 &	 Resnick,	 2008;	 Klöppel,	
Stonnington,	 Chu,	 &	 Draganski,	 2008;	 Lao,	 Shen,	 Xue,	 Karacali,	
&	Resnick,	 2004;	 Li,	 Shi,	 Pu,	 Li,	&	Jiang,	 2007;	Magnin,	Mesrob,	&	
Kinkingnéhun,	2009;	Morra,	Tu,	Apostolova,	&	Green,	2008;	Shankle,	
Mani,	 Pazzani,	 &	 Smyth,	 1997;	 Stonnington,	 Chu,	 Klöppel,	 &	 Jack,	
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2010;	Sun,	van	Erp,	Thompson,	&	Bearden,	2009;	Trambaiolli,	Lorena,	
&	Fraga,	2011;	Vemuri,	Gunter,	Senjem,	&	Whitwell,	2008;	Ye,	Wu,	
Li,	&	Chen,	2011;	Zhang	&	Shen,	2012;	Zhang,	Wang,	Zhou,	Yuan,	&	
Shen,	2011).	(Zhou	et	al.,	2013)	tackled	this	problem	by	using	a	con-
vex	 fused	 sparse	group	 lasso	 (cFSGL)	 framework	 that	 incorporated	
temporal smoothness to predict disease progression as measured by 
MMSE	and	CDR.	Generic	volumetric	and	cortical	thickness	generated	
by freesurfer was used as imaging features in addition to a host of 
other clinical descriptors.
However,	 combining	 cFSGL	with	 a	more	AD	 specific	 /	 sensitive	
features such as surface deformations fields of the hippocampus might 
improve the predictive power of the algorithm significantly. To this 
end,	we	augmented	the	generic	FreeSurfer-	based	image	features	with	
novel	mTBM	features	of	the	hippocampus	and	other	surface	deforma-
tion	field	based	features	(see	Table	1	for	features),	which	significantly	
increased	the	predictive	power	of	the	cFSGL	technique.
2  | METHODS
2.1 | ADNI data
Data used in the preparation of this article were obtained from the 
Alzheimer’s	 Disease	 Neuroimaging	 Initiative	 (ADNI)	 database	 (adni.
loni.usc.edu).	ADNI	was	 launched	 in	2003	by	 the	National	 Institute	
on	 Aging	 (NIA),	 the	 National	 Institute	 of	 Biomedical	 Imaging	 and	
Bioengineering	 (NIBIB),	 the	 Food	 and	 Drug	 Administration	 (FDA),	
private	pharmaceutical	companies	and	non-	profit	organizations,	as	a	
$60	million,	 5-	year	 public-	 private	 partnership.	 The	primary	 goal	 of	
ADNI	 has	 been	 to	 test	whether	 serial	magnetic	 resonance	 imaging	
(MRI),	 positron	 emission	 tomography	 (PET),	 other	 biological	 mark-
ers,	and	clinical	and	neuropsychological	assessment	can	be	combined	
to	measure	 the	progression	of	mild	cognitive	 impairment	 (MCI)	and	
early	Alzheimer’s	disease	(AD).	Determination	of	sensitive	and	specific	
markers	of	very	early	AD	progression	is	 intended	to	aid	researchers	
and clinicians to develop new treatments and monitor their effective-
ness,	as	well	as	lessen	the	time	and	cost	of	clinical	trials.
The	Principal	Investigator	of	this	initiative	is	Michael	W.	Weiner,	
MD,	VA	Medical	Center	and	University	of	California	–	San	Francisco.	
ADNI	is	the	result	of	efforts	of	many	co-	investigators	from	a	broad	
range	 of	 academic	 institutions	 and	 private	 corporations,	 and	 sub-
jects have been recruited from over 50 sites across the U.S. and 
Canada.	 The	 initial	 goal	 of	ADNI	was	 to	 recruit	 800	 subjects	 but	
ADNI	 has	 been	 followed	 by	ADNI-	GO	 and	ADNI-	2.	 ADNI-	GO	 or	
“Grand	 Challenges”	 and	 ADNI-	2	 supplements	 ADNI	 by	 trying	 to	
identify	 patients	 in	 the	 pre-	dementia	 or	 early	 mildly	 cognitively	
impaired	(eMCI)	phase.	To	date	these	three	protocols	have	recruited	
over	1500	adults,	ages	55	to	90,	to	participate	in	the	research,	con-
sisting	 of	 cognitively	 normal	 older	 individuals,	 people	 with	 early	
or	 late	MCI,	 and	 people	with	 early	AD.	The	 follow	up	 duration	 of	
each	 group	 is	 specified	 in	 the	 protocols	 for	ADNI-	1,	ADNI-	2	 and	
ADNI-	GO.	 Subjects	 originally	 recruited	 for	ADNI-	1	 and	ADNI-	GO	
had	 the	option	 to	be	 followed	 in	ADNI-	2.	For	up-	to-	date	 informa-
tion,	see	www.adni-info.org.
For	our	experiment	we	used	616	subjects	from	ADNI-	1	where	we	
had	606	subjects	that	have	behavioral	scores	for	M06,	606	for	M12,	
533	for	M24,	364	for	M36	and	97	for	M48.	Zhou	et	al.	(2013)	meth-
ods allows us to train prediction using data that have missing time 
points,	so	subjects	that	has	missing	time	points	can	be	used.	90%	of	
the	data	was	used	for	training	and	10%	used	for	testing.	The	reported	
results	are	for	20	different	selection	splits	of	training	and	testing.	More	
information about the demographics and patient selection is available 
in	(Zhou	et	al.,	2013).
2.2 | Freesurfer MRI features
The	MRI	image	analysis	software	Freesurfer	(Fischl,	2012)	was	used	to	
extract	305	MRI	features	based	on	cortical	reconstruction	and	volu-
metric segmentations. The features can be group into 5 categories: 
average	cortical	thickness,	standard	deviation	in	cortical	thickness,	the	
volumes of cortical parcellations (based on regions of interest auto-
matically	segmented	in	the	cortex),	the	volumes	of	specific	white	mat-
ter	parcellations,	and	the	total	surface	area	of	the	cortex.	This	process	
was	performed	by	the	ADNI	team	at	UCSF	under	the	ADNI	harmo-
nized	MRI	processing	protocols	as	outlined	on	their	website	(http://
adni.loni.usc.edu/methods/mri-analysis/).	 See	 Table	1	 for	 a	 more	
complete feature list and breakdown.
2.3 | Hippocampus surface computation
The	 details	 of	 the	 entire	 methodology	 of	 extracting	 mTBM	 fea-
tures	 from	 surface	 registered	 hippocampal	 maps	 is	 outlined	 in	 Shi,	
Thompson,	et	al.	(2013),	we	have	outlined	the	key	steps	of	the	method	
TABLE  1 List	of	original	features	from	(Zhou	et	al.,	2013)	and	
new	surface	features	(downsized	by	10)	computed	from	the	
hippocampus	used	to	predict	outcomes	at	6,	12,	24,	36	and	
48	months
No of features
Original features
Sex 1
309
Age 1
ApoE 1
Baseline	MMSE 1
MRI	features:	(average	cortical	thickness,	
standard	deviation	in	cortical	thickness,	the	
volumes of cortical parcellations (based on 
regions of interest automatically segmented in 
the	cortex),	the	volumes	of	specific	white	
matter	parcellations,	and	the	total	surface	area	
of	the	cortex.
305
Hippocampal	surface	features
Mid	Axis	Distance	map 300
2100
mTBM	feature	maps	(3	tensor	values	×	300	
points)
900
Jacobian	magnitude	map 300
Jacobian	principal	eigen	values	(2	×	300	points) 600
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F IGURE  1 Example	of	Feature	Maps	of	
the	Hippocampus	for	1	subject
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in	 this	 paper.	 FSL’s	 (Jenkinson,	 Beckmann,	 &	 Behrens,	 2012)	 auto-
mated	 segmentation	 program	FIRST	was	 used	 to	 segment	 the	MRI	
volumes	 to	 extract	 binary	 volumes	 for	 the	 hippocampus.	 The	 sur-
faces	were	then	computed	by	running	a	topology-	preserving	level	set	
method	 (Han,	Xu,	&	Prince,	 2003)	 to	 ensure	 the	 segmentation	was	
topological correct before tessellation via a marching cubes algorithm 
(Lorensen	&	Cline,	1987).
2.4 | Conformal representation and surface 
registration of the hippocampus
In	order	for	discretized	imaging	data	to	be	used	in	group	analysis	and	
prediction	tasks,	they	must	be	transformed	into	a	common	space	that	
allows	for	one-	to-	one	correspondence	across	subjects.	Examples	of	
the mean hippocampal common space can be seen in Figure 1. In 
our	case,	we	would	like	to	use	measurements	on	a	discretized	sur-
face represented my vertices in ℝ3 and edges between the vertices. 
In	this	case,	we	first	conformally	mapped	the	hippocampal	surface	
onto	a	rectangular	plannar	surface	using	holomorphic	1-	forms.	The	
surface conformal representation is then computed using the local 
conformal factor as well as mean curvature. The dynamic range of 
the conformal representation is then linearly scaled to form the fea-
ture image of the surface. The feature image aligned with a template 
image via fluid registration in a curvilinear coordinate system that 
compensates	 for	 distortions	 due	 to	 the	 conformal	 parameteriza-
tion	 (Shi,	Thompson,	et	al.	2013).	There	are	numerous	advantages	
of using conformal representation with fluid registration to align 
the	 hippocampal	 surfaces:	 (1)	 the	 entire	 transform	 is	 diffeomor-
phic and therefore has diffeomorphic shape correspondences that 
are	 smooth	 and	 one-	to-	one.	 (2)	 The	 transform	 is	 inverse	 consist-
ent and therefore more robust than unidirectional transformations 
(Leow	et	al.,	2005).	 (3)	Because	conformal	parametrization	induces	
a	simple	Riemannian	metric,	the	Navier-	Stokes	equation	in	the	fluid	
registration	can	be	easily	adjusted	for	area	distortion	(Wang,	Chiang,	
&	Thompson,	2005a,b).
2.5 | Multivariate tensor- based morphometry 
(mTBM)
After	automatically	segmenting	hippocampus	with	FSL	 (Jenkinson	
et	al.,	2012)	from	brain	MR	images,	we	build	parametric	meshes	to	
model	hippocampal	shapes.	High-	order	correspondences	between	
hippocampal surfaces were enforced across subjects with a novel 
inverse	 consistent	 surface	 fluid	 registration	method.	Multivariate	
statistics	 consisting	 of	 multivariate	 tensor-	based	 morphometry	
(mTBM)	and	 radial	distance	were	 computed	 for	 surface	deforma-
tion	analysis	(Shi,	Thompson,	et	al.	2013;	Wang,	Yuan,	et	al.,	2010).	
Multivariate	tensor-	based	morphometric	(mTBM)	analysis	has	been	
used as a sensitive method of comparing deformation fields of dif-
ferent	subjects	with	the	aim	of	discovering	group-	wise	differences	
(Lepore	et	al.,	2008;	Wang,	Zhang,	et	al.,	2010).	mTBM	generates	
Riemannian manifolds from the full deformation fields that map 
each subject to the template space and statistics are computed on 
these	manifolds.	 Specifically,	 compared	 to	 univariate	 TBM	which	
uses	the	Jacobian	of	the	transformation	that	mainly	describes	the	
volumetric	 changes,	mTBM	uses	 the	 full	deformation	 information	
by	 applying	 a	manifold	 version	 of	 Hotelling’s	 test	 to	 Riemannian	
manifolds	in	log-	euclidean	space.	The	idea	is	to	be	able	to	describe	
higher order transformations with a single metric instead of using 
derived	metrics	 from	 the	 Jacobian	 (see	 Figure	1	 for	 examples	 of	
mTBM	features).
Shi et al. 2013 showed that a surface derived from a reasonable 
segmentation	using	FSL	is	sensitive	enough	to	detect	group-	wise	dif-
ferences	in	the	mTBM	features.	Moreover,	mTBM	is	also	more	statis-
tically sensitive with better power as shown by false discovery rates 
(Lepore	 et	al.,	 2008).	 In	 this	work,	we’ve	 added	 these	 sensitive	 fea-
tures	to	the	existing	MR-	based	surface	area	and	volumetric	features	
to	boost	AD	prediction	accuracy.
2.6 | Convex fused sparse group lasso
Zhou	 et	al.	 (2013)	 proposed	 a	 powerful	multi-	tasked	 learning	 tech-
nique that incorporates sparsity as well as temporal smoothing for 
modeling	 a	 progressive	 disease	 model.	 In	 their	 formulation,	 each	
tasked can be though of a single forward predictor from baseline 
measurement to a measurement at a certain future time point. In 
their	case,	they	used	the	ADNI	dataset	and	predicted	ADAS	cognitive	
scores	6	months	after	baseline	(M06),	12	months	after	baseline	(M12),	
24	months	after	baseline	(M24),	36	months	after	baseline	(M36)	and	
48	months	after	baseline	(M48).	In	our	study	we	aim	to	use	the	same	
ADNI	 dataset	 but	 also	 incorporate	 7	 hippocampus	 surface	 feature	
maps	of	300	points	(2100	features	total)	and	compare	it	to	the	predic-
tive performance of using only simple regional volumes and surface 
areas	used	(305	features	total)	in	their	study.
The	 cFSGL	method	 that	we	 use	 can	 be	 considered	 a	multi-	task	
regression problem with t time points and from n subjects each with d 
features,	where	
{
x1, x2,… , xn
}
 represents each of the d input features 
TABLE  2 Comparison	of	model	performance	in	predicting	ADA	
Cognitive	Score	with	and	without	mTBM	features.	The	base	set	of	
features	used	were	MRI	information	(305	features),	Sex,	Gender,	
Age,	ApoE	and	baseline	MMSE	score.	7	Hippocampus	feature	maps	
were	used:	Mid	Distance,	3	lambda	values	of	the	mTBM,	magnitude	
of	the	Jacobian	map	and	the	first	two	eigenvalues	of	the	Jacobian	
(See	Table	1	and	Figure	1	for	more	details)
Without hippocampal 
features
With 
hippocampal 
features
nMSE 0.345	±	0.075 0.249	±	0.039
wR 0.828	±	0.036 0.873	±	0.022
M06	rMSE 5.259	±	0.872 4.534	±	0.883
M12	rMSE 5.653	±	1.143 4.989	±	1.134
M24	rMSE 5.532	±	1.029 4.885	±	1.094
M36	rMSE 4.777	±	0.833 4.055	±	1.024
M48	rMSE 4.367	±	1.179 3.164	±	1.091
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for each subject at baseline (i.e. xi∈ℝd	).	Similarly,	
{
y1, y2,… , yn
}
 rep-
resents the target cognitive scores for each subject at T time points 
(i.e. yi∈ℝt).	For	a	single	subject	 (n),	each	task	can	be	seen	as	a	pro-
jection	 of	 MR	 /	 demographic	 /	 genetic	 baseline	 measurements	 at	
t = 0 represented as xn to a future cognitive score measurement at 
time t = t1	(e.g.	at	48	months)	given	by	the	appropriate	row	in	vector	
yn.	We	can	extend	this	formulation	to	a	multi-	task	one	by	performing	
projections	of	all	time	points	simultaneously.	In	other	words,	each	set	
of baseline measurements for a single subject at t = 0 given by x1 (ℝd 
with d	features)	is	projected	to	a	vector	(ℝt with T	time	points)	given	
by y1.	The	entire	population-	based	mapping	can	be	summarized	as	a	
linear operation using matrices X and Y. X and Y are formed by arrang-
ing	 the	 input	 and	 output	 patient	 feature	 space	 row-	wise,	 each	 row	
being xn or yn,	 (i.e.	X=
[
x1, x2,… , xn
]T
,Y=
[
y1, y2,… , yn
]T)	 and	yield	a	
X∈ℝn×d	matrix	 and	 a	Y∈ℝn×t	matrix.	 Since	 this	 is	 a	 linear	model,	 a	
set of weights W=
[
w1,w2,… ,wt
]T
∈ℝd×t is trained to map xn to yn 
or X to Y.
To achieve a set of weights that encodes both sparsity and tem-
poral	 smoothness,	 the	 following	 cost	 function	 is	 minimized	 during	
training:
where ||W1||	is	the	L1-	norm	or	lasso	penalty	that	encodes	for	sparsity,	
��W2,1��=
∑d
i=1
�∑t
j=1
W
2
ij
	is	the	group	Lasso	penalty	that	encodes	for	
temporal grouping of features.
||RWT||1 is the fused lasso penalty as defined by R = H
T,	where:
this	term	encodes	for	temporal	smoothness	(Zhou	et	al.,	2013).
3  | RESULTS
Predictions	using	hippocampus-	based	feature	maps	outperform	pre-
diction without using feature maps as shown by quantitative meas-
ures	such	as	nMSE,	wR	and	rMSE.	This	was	true	across	the	board	at	all	
time	points	(see	Table	2	and	Figure	2).	Our	results	show	that	incorpo-
rating large feature maps into sparsifying prediction tasks is not only 
possible but may improve results of the prediction.
The	 results	 shown	 are	 from	 2	 simulation	 experiments	 where	
data	 from	ADNI	was	used	 to	 both	 train	 and	 test	 the	 cFSGL	model.	
Experiment	 1	 uses	 demographic	 information	 (age	 and	 gender),	
FreeSurfer	volumes	and	cortical	thicknesses	(326	features),	the	num-
ber	of	ApoE-	ε4	alleles	as	well	as	a	baseline	MMSE	score	as	features	
used	 in	 the	 model.	 Experiment	 2	 added	 the	 hippocampus	 features	
from each of the vertices of the hippocampus segmentation using 
FreeSurfer.	The	vertex	information	from	the	hippocampus	was	scaled	
down	by	 a	 factor	 10	 using	 bi-	cubic	 interpolation	 to	yield	 a	 total	 of	
2100	features.	90	percent	of	the	624	subjects	were	used	for	training	
and the remaining 10 percent were used for testing. The results shown 
are from the 10 percent of our dataset allocated for testing. We calcu-
lated the root mean square error:
as well as a the correlation coefficient between the pairs of predicted 
values and actual values at each of the time points.
Table 2 shows how predictive performance has improved by incor-
porating hippocampus surface features into our dataset. There were 
improvements in predicting behavior outcomes at every time point. 
Moreover,	by	looking	at	the	weights	in	predicting	the	behavioral	out-
comes,	we	may	able	to	see	which	parts	of	the	hippocampus	feature	
maps	are	often	used	in	predicting	behavior.	Figures	3	and	4	show	that	
the raw prediction results from our multiple cross validation runs are 
reasonably distributed. These results were then used to calculate the 
different	predictive	performance	measures	such	as	Mean	Square	Error.
4  | DISCUSSION AND CONCLUSIONS
By	merging	fused	multi-	task	learning	that	encodes	temporal	smooth-
ing	(Zhou	et	al.,	2013)	together	with	AD	sensitive	mTBM	maps	of	the	
parametric	 hippocampus	 surface	 (Shi,	 Thompson,	 et	al.	 2013),	 we	
were	able	to	get	significant	gains	in	future	ADAS	cognitive	score	pre-
diction. These results are some of the highest performing predictions 
based on baseline data only and is consistent with our survey of other 
comparable	studies	 (Zhou	et	al.,	2013).	There	are	two	main	findings	
in	 our	work.	 First,	we	 demonstrate	 surface	mTBM	when	 combined	
with	 other	 features,	 may	 significantly	 boost	 the	 statistical	 powers.	
This	discovery	is	 in	 line	with	many	of	our	prior	studies	(Wang	et	al.,	
2011;	Shi,	Wang,	et	al.,	2013;	Wang	et	al.,	2013;	Shi	et	al.,	2014).	The	
newly combined surface statistics practically encodes a great deal 
of neighboring intrinsic geometry information that would otherwise 
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F IGURE  2 Bar	Chart	of	the	rMSE	of	predictions	with	and	
without	hippocampal	features	by	time	points	(6	months,	12	months,	
24	months,	36	months,	48	months)
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be	 inaccessible,	 or	 overlooked.	 Second,	 cFSGL	 is	 an	 effective	 way	
to	overcome	the	curse	of	the	dimension	with	it’s	sparsity	constraint.	
With	proper	tuning	of	parameters	to	match	the	features	size,	the	spar-
sity	 constraint	was	 also	 able	 to	 prevent	 overfitting,	which	 tends	 to	
occur when using large number of features. Our work shed some light 
to future work to predict longitudinal neuropsychological changes and 
may help solve this challenging research problem.
One factor not addressed in this work is the effect of percentage 
of	data	used	for	training	and	testing.	Previous	work	(Zhou	et	al.,	2013)	
has shown that although there would be a decrease in performance 
measured	with	a	smaller	 training	set,	 the	trends	and	relative	perfor-
mance remains comparable. We have also treated the parametric sur-
face	data,	 patient	demographics	 and	MRI	volumetric	 information	 as	
one continuous information vector. It would be interesting to see if 
adding neighborhood information based on the location on the para-
metric surface would give us smoother and more realistic weights on 
the parametric surface and perhaps even better or more consistent 
results.
The current study also serves as an illustration of how machine 
learning methods can be used with whole parametric surfaces or even 
volumetric	volumes	 such	 as	 in	 fMRI	 studies.	However,	 as	 the	 num-
ber	of	voxels	and	vertex	points	increase,	we	again	run	into	problems	
with	the	curse	of	dimensionality.	To	counter	such	problems,	sparsify-
ing	penalties	such	as	in	cFSGL	can	be	employed.	However,	without	a	
reasonable	starting	weight,	finding	a	reasonable	solution	that	has	the	
required sparsity can get computational intensive. One solution that 
F IGURE  3 Prediction	of	ADAS	Cog	Score	vs.	Actual	ADAS	Cog	Score	without using	mTBM	features	and	only	with	MRI	volumetric	
information,	Age,	Sex,	Gender,	ApoE	and	baseline	MMSE	score	at	M06	(6	months),	M12	(12	months),	M24	(24	months),	M36	(36	months),	M48	
(48	months)
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we	 intend	 to	explore	 is	 the	use	of	 stability	 selection	 in	 seeding	 the	
initial weights for the algorithm in a hierarchical approach to learning. 
We believe that this a reasonable way of leveraging prior informa-
tion	whilst	allowing	the	algorithm	to	impose	explore	ensure	temporal	
smoothness and sparsity.
As	this	is	a	model	of	an	epidemiological	system,	we	cannot	ignore	
the	investigator’s	selection	of	reasonable	features.	Moreover,	the	per-
formance of the system is as interesting as the weights that yield the 
predictions.
4.1 | Future Work
Our future work includes understanding the behavior of the weights 
across the parametric surface space as well as in time. Previous work 
has	shown	that	stability	selection	may	be	a	good	fit	for	analyzing	the	
feature weights on the model and may yield more information about 
the relationship between the deformation of hippocampal subfields 
and	other	clinical	 indicators	during	AD	progression.	Moreover,	addi-
tional work can be done to investigate the specifics of how the addi-
tion	of	 the	 large	number	of	mTBM	 features	has	 contributed	 to	 the	
final prediction results as well as the computational burden versus 
reward of the additional features.
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